July 16, 2022 Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
July 16, 2022 Comments Off on New patent expiration for Acrotech drug FOLOTYN Posted in: Uncategorized
Annual Drug Patent Expirations for FOLOTYN Folotyn is a drug marketed by Acrotech and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Acrotech drug FOLOTYN appeared first…
